Optimization of Tolerability and Efficacy of Dual Amylin and Calcitonin Receptor Agonist, KBP-089, Through Dose Escalation and Combination With a GLP-1 Analogue

American Journal of Physiology - Endocrinology and Metabolism - United States
doi 10.1152/ajpendo.00419.2016

Related search